Kathelijne Peerlinck
- Hematology top 0.2%
- Genetics top 2%
- Molecular Biology
- Surgery top 10%
- Cardiology and Cardiovascular Medicine top 5%
- Co-authors
- Jos VermylenMarc JacqueminJef ArnoutJean‐Marie Saint‐RemyRenaud Lavend’hommeMarc HoylaertsJean Guy GillesHans Deckmyn
- Topics
- Hemophilia Treatment and Research (73 papers)Platelet Disorders and Treatments (53 papers)Blood Coagulation and Thrombosis Mechanisms (38 papers)
- Cited by
- HematologyInternal MedicineGenetics
- Partner nations
- BelgiumUnited StatesNetherlands
In The Last Decade
Kathelijne Peerlinck
129 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Hematology 2.5k
- Genetics 579
- Molecular Biology 459
- Surgery 389
- Cardiology and Cardiovascular Medicine 355
Countries citing papers authored by Kathelijne Peerlinck
This map shows the geographic impact of Kathelijne Peerlinck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathelijne Peerlinck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathelijne Peerlinck more than expected).
Fields of papers citing papers by Kathelijne Peerlinck
This network shows the impact of papers produced by Kathelijne Peerlinck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathelijne Peerlinck. The network helps show where Kathelijne Peerlinck may publish in the future.
Co-authorship network of co-authors of Kathelijne Peerlinck
This figure shows the co-authorship network connecting the top 25 collaborators of Kathelijne Peerlinck. A scholar is included among the top collaborators of Kathelijne Peerlinck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathelijne Peerlinck. Kathelijne Peerlinck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 13 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 14 | |
| 7 | Deficit of Functional Ankle Muscle Strength is Not Found in Young Haemophiliacs With Confirmed Structural Impairment | 1 |
| 8 | DDAVP in moderate hemophilia a patients: a treatment strategy worth considering | 1 |
| 9 | The type of reagents determines the accuracy of calibration with a product specific standard for the measurement of the B-domain deleted RFVIII Moroctocog alfa-AF activity | 1 |
| 10 | 35 | |
| 11 | Long-lasting recombinant factor FIX Fc fusion (rFIXFc) for perioperative management of subjects with haemophilia B in the phase 3 B-LONG study | 4 |
| 12 | Activation of human endothelial cells induces the release of a FVIII storage pool | 1 |
| 13 | 75 | |
| 14 | Occlusion in totally implantable vascular access devices: what is its incidence and what actions do nurses take to restore patency? | 1 |
| 15 | Response to DDAVP in mild/moderate haemophilia A patients according to the underlying Factor VIII genotype | 4 |
| 16 | 77 | |
| 17 | A patient with mild hemophilia A and a high titer antifactor VIII antibody against exogenous factor VIII only: clinical features, surgical management, and partial characterization of the inhibitor | 3 |
| 18 | A murine monoclonal-antibody against vonwillebrand-factor (vwf) increases vwf binding to human platelet glycoprotein (gp) ib and gp iib/iiia | 2 |
| 19 | Measurement of vonwillebrand-factor antigen in plasma and platelets with an enzyme-linked-immunosorbent-assay based on 2 murine monoclonal-antibodies | 1 |
| 20 | An easy method to detect patients with vonwillebrand-factor defective in fviii-binding | 1 |
About Kathelijne Peerlinck
Kathelijne Peerlinck is a scholar working on Hematology, Internal Medicine and Genetics, having authored 133 papers that have together received 3.5k indexed citations. Recurring topics across this work include Hemophilia Treatment and Research (73 papers), Platelet Disorders and Treatments (53 papers) and Blood Coagulation and Thrombosis Mechanisms (38 papers). The work is most often cited by research in Hematology (2.5k citations), Internal Medicine (217 citations) and Genetics (579 citations). Kathelijne Peerlinck has collaborated with scholars based in Belgium, United States and Netherlands. Frequent co-authors include Jos Vermylen, Marc Jacquemin, Jef Arnout, Jean‐Marie Saint‐Remy, Renaud Lavend’homme, Marc Hoylaerts, Jean Guy Gilles, Hans Deckmyn, J. Vermylen and Katrien Devreese. Their work appears in journals such as The Lancet, Circulation and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.